Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
NanoString Technologies, Inc. NSTG
$8.51
-$0.2 (-2.30%)
На 18:00, 12 мая 2023
+152.64%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
397603920.00000000
-
week52high
18.51
-
week52low
4.37
-
Revenue
127262000
-
P/E TTM
-3
-
Beta
1.63252500
-
EPS
-3.43000000
-
Last Dividend
0.00000000
-
Next Earnings Date
02 авг 2023 г. в 10:59
Описание компании
NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics. It has collaboration with Lam Research Corporation for the research and development of Hyb & Seq technologies; Celgene Corporation for developing LymphMark, an in vitro diagnostic for the treatment of diffuse large B-cell lymphoma; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Morgan Stanley | Equal-Weight | Equal-Weight | 08 авг 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 11 мая 2022 г. |
| Canaccord Genuity | Buy | Buy | 13 апр 2022 г. |
| Canaccord Genuity | Buy | 24 мар 2022 г. | |
| JP Morgan | Overweight | Overweight | 02 мар 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 09 ноя 2022 г. |
| Cowen & Co. | Outperform | Outperform | 08 ноя 2022 г. |
| Baird | Outperform | Outperform | 08 ноя 2022 г. |
| UBS | Buy | 02 февр 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Bailey K Thomas | D | 0 | 4050 | 26 янв 2023 г. |
| Bailey K Thomas | D | 50774 | 1809 | 26 янв 2023 г. |
| Bailey K Thomas | A | 52583 | 4050 | 26 янв 2023 г. |
| BEECHEM JOSEPH M | D | 0 | 3038 | 26 янв 2023 г. |
| BEECHEM JOSEPH M | D | 86885 | 1607 | 26 янв 2023 г. |
| BEECHEM JOSEPH M | A | 88492 | 3038 | 26 янв 2023 г. |
| GRAY R BRADLEY | D | 0 | 13364 | 26 янв 2023 г. |
| GRAY R BRADLEY | D | 277558 | 5804 | 26 янв 2023 г. |
| GRAY R BRADLEY | A | 283362 | 13364 | 26 янв 2023 г. |
| GERACE JOHN D. | D | 41886 | 20943 | 09 янв 2023 г. |
Новостная лента
NanoString Technologies (NSTG) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research
03 мая 2023 г. в 19:02
NanoString Technologies (NSTG) came out with a quarterly loss of $0.88 per share versus the Zacks Consensus Estimate of a loss of $0.72. This compares to loss of $0.86 per share a year ago.
NanoString to Release First Quarter 2023 Operating Results and Host Conference Call on Wednesday, May 3, 2023
Business Wire
10 апр 2023 г. в 06:00
SEATTLE--(BUSINESS WIRE)--NanoString to report Q1 2023 operating results on May 3, 2023.
NanoString to Webcast Panel on AI-Based Genomics and Drug Discovery from the 43rd Annual Cowen Health Care Conference
Business Wire
01 мар 2023 г. в 06:00
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to participate in a panel discussion, “AI-Driven Disruptions To Genomics & Computational Drug Discovery”, from the 43rd Annual Cowen Health Care Conference. The conference will be held March 6-8, 2023.
NanoString Technologies (NSTG) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research
28 февр 2023 г. в 18:49
NanoString (NSTG) delivered earnings and revenue surprises of -55.74% and 3.84%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
NanoString to Webcast Presentation from the 43rd Annual Cowen Health Care Conference
Business Wire
23 февр 2023 г. в 06:00
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast a presentation from the 43rd Annual Cowen Health Care Conference. The conference will be held March 6-8, 2023. Brad Gray, president and chief executive officer, is scheduled to present on Tuesday, March 7, 2023, at 1:30pm ET.